Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
The more formal title should be: Randomized phase II results – lenalidomide is not a viable option post-allogeneic stem cell transplant for persistent chronic lymphocytic leukemia (CLL). So what does this
We have reported on the justified excitement about CAR-T therapy, especially now with the recent FDA oncology board recommendation for approval of CAR-T for acute lymphoblastic leukemia (ALL) (see: http://cllsociety.org/2017/07/fda-panel-recommends-approval-gene-altering-leukemia-treatment/) But
By Mark Hoffman – Patient This is the story of how I got to the treatment that was most likely by far the best for my genetics. I was first diagnosed
By Deborah M. Stephens, DO I have got tons of extra white blood cells. That helps me to fight infection, right? Wrong. Although normal white blood cells fight infection, abnormal white
May 5, 2017 marked 5 years since I swallowed my first 3 capsules of PCI-32765, now better known as ibrutinib or Imbruvica. I still take 3 battleship grey capsules every morning
I was diagnosed with CLL in July 2013. I had a blood test for a sore throat. The lymphocyte count was only 5 – borderline – but it was a shock. My wife and I met with the oncologist who told us we were on “watch and wait”, with blood tests every six months. I had no lymph nodes and my hemoglobin and platelets were fine. But like most patients we weren’t entirely comfortable with watch and wait.
In 1928, Dr. Richter described a patient with chronic lymphocytic leukemia (CLL), who progressed to develop an aggressive large cell lymphoma. Richter syndrome (RS), also called Richter transformation, is now understood to describe the development of an aggressive lymphoma in patients with CLL or small lymphocytic lymphoma (SLL).
By Michael Choi, MD It is a tremendous understatement to say that one should not take a “one-size fits all” approach to the treatment of patients with chronic lymphocytic leukemia. There
Chronic Lymphocytic Leukemia (CLL) is a very unique type of cancer. It is usually slow to progress, it sometimes has no initial symptoms, and more often than not, it does not
One click to our most popular content.
